As a tumor-associated protein, Annexin A2 promotes cancer progression including proliferation, invasion and metastasis in nasopharyngeal carcinoma, ovarian cancer, gliomas, hepatomas, pancreatic cancer and so on [28–31]. Here, ANXA2 is linked to hepatocellular carcinoma.